452 related articles for article (PubMed ID: 28404927)
1. Prognostic role of B7-H4 in patients with non-small cell lung cancer: A meta-analysis.
Tan Z; Shen W
Oncotarget; 2017 Apr; 8(16):27137-27144. PubMed ID: 28404927
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of B7-H3 correlates with aggressive clinicopathological characteristics in non-small cell lung cancer.
Wu S; Zhao X; Wu S; Du R; Zhu Q; Fang H; Zhang X; Zhang C; Zheng W; Yang J; Feng H
Oncotarget; 2016 Dec; 7(49):81750-81756. PubMed ID: 27835582
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of B7-H4 in pancreatic cancer: Systematic review and meta-analysis.
Chen X; Tao L; Yuan C; Xiu D
Medicine (Baltimore); 2018 Mar; 97(12):e0088. PubMed ID: 29561406
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of high B7-H4 expression in patients with solid tumors: a meta-analysis.
Song X; Shao Y; Gu W; Xu C; Mao H; Pei H; Jiang J
Oncotarget; 2016 Nov; 7(47):76523-76533. PubMed ID: 27058425
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
Liu X; Huang G; Zhang J; Zhang L; Liang Z
PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
[TBL] [Abstract][Full Text] [Related]
6. The B7-H4 gene induces immune escape partly via upregulating the PD-1/Stat3 pathway in non-small cell lung cancer.
Yuan L; Ye J; Fan D
Hum Immunol; 2020 May; 81(5):254-261. PubMed ID: 32113654
[TBL] [Abstract][Full Text] [Related]
7. Elevated CD147 expression is associated with shorter overall survival in non-small cell lung cancer.
Zhang X; Tian T; Zhang X; Liu C; Fang X
Oncotarget; 2017 Jun; 8(23):37673-37680. PubMed ID: 28445149
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of angiopoietin-2 in non-small cell lung cancer patients: a meta-analysis.
Xuan ZX; Zhang S; Yuan SJ; Wang W; Yu J
World J Surg Oncol; 2016 Sep; 14(1):237. PubMed ID: 27589869
[TBL] [Abstract][Full Text] [Related]
9. The clinicopathologic impacts and prognostic significance of GLUT1 expression in patients with lung cancer: A meta-analysis.
Zhang B; Xie Z; Li B
Gene; 2019 Mar; 689():76-83. PubMed ID: 30552981
[TBL] [Abstract][Full Text] [Related]
10. A meta-analysis for CXCR4 as a prognostic marker and potential drug target in non-small cell lung cancer.
Zhang C; Li J; Han Y; Jiang J
Drug Des Devel Ther; 2015; 9():3267-78. PubMed ID: 26150700
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of CD44 expression in non-small cell lung cancer: a systematic review.
Luo Z; Wu RR; Lv L; Li P; Zhang LY; Hao QL; Li W
Int J Clin Exp Pathol; 2014; 7(7):3632-46. PubMed ID: 25120740
[TBL] [Abstract][Full Text] [Related]
12. Does B7-H4 expression correlate with clinicopathologic characteristics and survival in ovarian cancer?: A systematic review and PRISMA-compliant meta-analysis.
Ye Y; Wang JJ; Li SL; Wang SY; Jing FH
Medicine (Baltimore); 2018 Aug; 97(32):e11821. PubMed ID: 30095655
[TBL] [Abstract][Full Text] [Related]
13. B7-H4 is Predictive of Poor Prognosis in Patients with Gastric Cancer.
Cui Y; Li Z
Med Sci Monit; 2016 Nov; 22():4233-4237. PubMed ID: 27820598
[TBL] [Abstract][Full Text] [Related]
14. B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes.
Altan M; Pelekanou V; Schalper KA; Toki M; Gaule P; Syrigos K; Herbst RS; Rimm DL
Clin Cancer Res; 2017 Sep; 23(17):5202-5209. PubMed ID: 28539467
[No Abstract] [Full Text] [Related]
15. Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC).
Carvajal-Hausdorf D; Altan M; Velcheti V; Gettinger SN; Herbst RS; Rimm DL; Schalper KA
J Immunother Cancer; 2019 Mar; 7(1):65. PubMed ID: 30850021
[TBL] [Abstract][Full Text] [Related]
16. B7-H4 is a prognostic biomarker for poor survival in patients with pancreatic cancer.
Shen L; Qian Y; Wu W; Weng T; Wang FXC; Hong B; Wu Z; Wang Q; Sang Y; Zhang H; Zhou X; Yao H
Hum Pathol; 2017 Aug; 66():79-85. PubMed ID: 28600225
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological and prognostic value of S100A4 expression in non-small cell lung cancer: a meta-analysis.
Zhang J; Gu Y; Liu X; Rao X; Huang G; Ouyang Y
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32696952
[TBL] [Abstract][Full Text] [Related]
18. A meta-analysis reveals prognostic role of programmed death ligand-1 in Asian patients with non-small cell lung cancer.
Hu XY; Zhang W; Hu Y; Zhang Y; Gong R; Liang JY; Liu L
J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):313-320. PubMed ID: 27376797
[TBL] [Abstract][Full Text] [Related]
19. Association of ERCC1-C118T and -C8092A polymorphisms with lung cancer risk and survival of advanced-stage non-small cell lung cancer patients receiving platinum-based chemotherapy: a pooled analysis based on 39 reports.
Xu TP; Shen H; Liu LX; Shu YQ
Gene; 2013 Sep; 526(2):265-74. PubMed ID: 23727606
[TBL] [Abstract][Full Text] [Related]
20. PD-L1 expression in lung cancer and its correlation with driver mutations: a meta-analysis.
Zhang M; Li G; Wang Y; Wang Y; Zhao S; Haihong P; Zhao H; Wang Y
Sci Rep; 2017 Aug; 7(1):10255. PubMed ID: 28860576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]